
Antibiotic Resistance Global Market Report 2025
Description
Antibiotic Resistance Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on antibiotic resistance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for antibiotic resistance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antibiotic resistance market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Drug Class: Beta Lactum Antibiotic; Cephalosporins; Quinolones Antibiotics; Macrolide Antibiotics; Tetracyclines; Oxazolidinones; Other Drug Classes
2) By Pathogen: Staphylococcus Aureus; Staphylococcus Pneumonia; Neisseria Gonorrhoeae; Enterococcus Faecium; Escherichia Coli; Klebsiella Pneumonia; Shigella; Clostridium Difficile; Other Pathogens
3) By Disease Type: Urinary Tract Infection; Intra-Abdominal Infection; Blood Stream infections; Clostridium Difficile Infections; Other Disease Types
4) By Mechanism Of Action: Protein Synthesis Inhibitors; Cell Wall Synthesis Inhibitors; RNA Synthesis Inhibitors; DNA Synthesis Inhibitors; Other Mechanism Of Actions
5) By End Users: Hospitals; Homecare; Specialty Clinics; Other End-users
Subsegments:
1) By Beta Lactam Antibiotics: Penicillins; Cephalosporins; Carbapenems; Monobactams
2) By Cephalosporins: First-generation; Second-generation; Third-generation; Fourth-generation
3) By Quinolones Antibiotics: Fluoroquinolones; Other Quinolones
4) By Macrolide Antibiotics: Erythromycin; Azithromycin; Clarithromycin
5) By Tetracyclines: Doxycycline; Minocycline; Tetracycline
6) By Oxazolidinones: Linezolid; Tedizolid
7) By Other Drug Classes: Glycopeptides; Lipopeptides; Streptogramins; Polymyxins
Companies Mentioned: Pfizer Inc.; Johnson and Johnson; F. Hoffmann-La Roche Ltd; AbbVie Inc.; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on antibiotic resistance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for antibiotic resistance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antibiotic resistance market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Drug Class: Beta Lactum Antibiotic; Cephalosporins; Quinolones Antibiotics; Macrolide Antibiotics; Tetracyclines; Oxazolidinones; Other Drug Classes
2) By Pathogen: Staphylococcus Aureus; Staphylococcus Pneumonia; Neisseria Gonorrhoeae; Enterococcus Faecium; Escherichia Coli; Klebsiella Pneumonia; Shigella; Clostridium Difficile; Other Pathogens
3) By Disease Type: Urinary Tract Infection; Intra-Abdominal Infection; Blood Stream infections; Clostridium Difficile Infections; Other Disease Types
4) By Mechanism Of Action: Protein Synthesis Inhibitors; Cell Wall Synthesis Inhibitors; RNA Synthesis Inhibitors; DNA Synthesis Inhibitors; Other Mechanism Of Actions
5) By End Users: Hospitals; Homecare; Specialty Clinics; Other End-users
Subsegments:
1) By Beta Lactam Antibiotics: Penicillins; Cephalosporins; Carbapenems; Monobactams
2) By Cephalosporins: First-generation; Second-generation; Third-generation; Fourth-generation
3) By Quinolones Antibiotics: Fluoroquinolones; Other Quinolones
4) By Macrolide Antibiotics: Erythromycin; Azithromycin; Clarithromycin
5) By Tetracyclines: Doxycycline; Minocycline; Tetracycline
6) By Oxazolidinones: Linezolid; Tedizolid
7) By Other Drug Classes: Glycopeptides; Lipopeptides; Streptogramins; Polymyxins
Companies Mentioned: Pfizer Inc.; Johnson and Johnson; F. Hoffmann-La Roche Ltd; AbbVie Inc.; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Antibiotic Resistance Market Characteristics
- 3. Antibiotic Resistance Market Trends And Strategies
- 4. Antibiotic Resistance Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
- 5. Global Antibiotic Resistance Growth Analysis And Strategic Analysis Framework
- 5.1. Global Antibiotic Resistance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Antibiotic Resistance Market Growth Rate Analysis
- 5.4. Global Antibiotic Resistance Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Antibiotic Resistance Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Antibiotic Resistance Total Addressable Market (TAM)
- 6. Antibiotic Resistance Market Segmentation
- 6.1. Global Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Beta Lactum Antibiotic
- Cephalosporins
- Quinolones Antibiotics
- Macrolide Antibiotics
- Tetracyclines
- Oxazolidinones
- Other Drug Classes
- 6.2. Global Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Staphylococcus Aureus
- Staphylococcus Pneumonia
- Neisseria Gonorrhoeae
- Enterococcus Faecium
- Escherichia Coli
- Klebsiella Pneumonia
- Shigella
- Clostridium Difficile
- 6.3. Global Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Urinary Tract Infection
- Intra-Abdominal Infection
- Blood Stream infections
- Clostridium Difficile Infections
- Other Disease Types
- 6.4. Global Antibiotic Resistance Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Protein Synthesis Inhibitors
- Cell Wall Synthesis Inhibitors
- RNA Synthesis Inhibitors
- DNA Synthesis Inhibitors
- Other Mechanism Of Actions
- 6.5. Global Antibiotic Resistance Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Homecare
- Specialty Clinics
- Other End-users
- 6.6. Global Antibiotic Resistance Market, Sub-Segmentation Of Beta Lactam Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Penicillins
- Cephalosporins
- Carbapenems
- Monobactams
- 6.7. Global Antibiotic Resistance Market, Sub-Segmentation Of Cephalosporins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- First-generation
- Second-generation
- Third-generation
- Fourth-generation
- 6.8. Global Antibiotic Resistance Market, Sub-Segmentation Of Quinolones Antibiotics,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Fluoroquinolones
- Other Quinolones
- 6.9. Global Antibiotic Resistance Market, Sub-Segmentation Of Macrolide Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Erythromycin
- Azithromycin
- Clarithromycin
- 6.10. Global Antibiotic Resistance Market, Sub-Segmentation Of Tetracyclines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Doxycycline
- Minocycline
- Tetracycline
- 6.11. Global Antibiotic Resistance Market, Sub-Segmentation Of Oxazolidinones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Linezolid
- Tedizolid
- 6.12. Global Antibiotic Resistance Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Glycopeptides
- Lipopeptides
- Streptogramins
- Polymyxins
- 7. Antibiotic Resistance Market Regional And Country Analysis
- 7.1. Global Antibiotic Resistance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Antibiotic Resistance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Antibiotic Resistance Market
- 8.1. Asia-Pacific Antibiotic Resistance Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Antibiotic Resistance Market
- 9.1. China Antibiotic Resistance Market Overview
- 9.2. China Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Antibiotic Resistance Market
- 10.1. India Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Antibiotic Resistance Market
- 11.1. Japan Antibiotic Resistance Market Overview
- 11.2. Japan Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Antibiotic Resistance Market
- 12.1. Australia Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Antibiotic Resistance Market
- 13.1. Indonesia Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Antibiotic Resistance Market
- 14.1. South Korea Antibiotic Resistance Market Overview
- 14.2. South Korea Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Antibiotic Resistance Market
- 15.1. Western Europe Antibiotic Resistance Market Overview
- 15.2. Western Europe Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Antibiotic Resistance Market
- 16.1. UK Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Antibiotic Resistance Market
- 17.1. Germany Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Antibiotic Resistance Market
- 18.1. France Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Antibiotic Resistance Market
- 19.1. Italy Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Antibiotic Resistance Market
- 20.1. Spain Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Antibiotic Resistance Market
- 21.1. Eastern Europe Antibiotic Resistance Market Overview
- 21.2. Eastern Europe Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Antibiotic Resistance Market
- 22.1. Russia Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Antibiotic Resistance Market
- 23.1. North America Antibiotic Resistance Market Overview
- 23.2. North America Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Antibiotic Resistance Market
- 24.1. USA Antibiotic Resistance Market Overview
- 24.2. USA Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Antibiotic Resistance Market
- 25.1. Canada Antibiotic Resistance Market Overview
- 25.2. Canada Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Antibiotic Resistance Market
- 26.1. South America Antibiotic Resistance Market Overview
- 26.2. South America Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Antibiotic Resistance Market
- 27.1. Brazil Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Antibiotic Resistance Market
- 28.1. Middle East Antibiotic Resistance Market Overview
- 28.2. Middle East Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Antibiotic Resistance Market
- 29.1. Africa Antibiotic Resistance Market Overview
- 29.2. Africa Antibiotic Resistance Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Antibiotic Resistance Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Antibiotic Resistance Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Antibiotic Resistance Market Competitive Landscape And Company Profiles
- 30.1. Antibiotic Resistance Market Competitive Landscape
- 30.2. Antibiotic Resistance Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 31. Antibiotic Resistance Market Other Major And Innovative Companies
- 31.1. Merck and Co. Inc.
- 31.2. Bristol-Myers Squibb
- 31.3. Sanofi S.A.
- 31.4. Thermo Fisher Scientific Inc
- 31.5. AstraZeneca
- 31.6. GlaxoSmithKline Plc
- 31.7. Eli Lilly and Company
- 31.8. Boehringer Ingelheim International GmbH
- 31.9. Astellas Pharma
- 31.10. Daiichi Sankyo
- 31.11. Chugai Pharmaceutical Co. Ltd.
- 31.12. Teva Pharmaceutical Industries Ltd.
- 31.13. Bio-Rad Laboratories Inc
- 31.14. Eppendorf Corporation
- 31.15. Takara Bio Inc
- 32. Global Antibiotic Resistance Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Antibiotic Resistance Market
- 34. Recent Developments In The Antibiotic Resistance Market
- 35. Antibiotic Resistance Market High Potential Countries, Segments and Strategies
- 35.1 Antibiotic Resistance Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Antibiotic Resistance Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Antibiotic Resistance Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.